The American Journal of Managed Care

EHA 2026 Had Something for Everyone, From Pediatric Practitioners to “Myeloma Maniacs”

EHA 2026 highlights included practice-changing immunotherapy data in relapsed/refractory multiple myeloma and high-risk pediatric B-cell ALL, plus insights on childhood cancer predisposition.
The American Journal of Managed Care

Phase 1 UCART22 Trial Shows Promising Activity in R/R B-Cell ALL: Nitin Jain, MD

Phase 1 BALLI-01 trial results showed promising UCART22 activity in R/R B-cell ALL, with higher remission rates after a ...
The American Journal of Managed Care

FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs

Tebipenem pivoxil becomes the only FDA-approved oral carbapenem for complicated UTIs/pyelonephritis in adults lacking viable ...
The American Journal of Managed Care

SUNMO: ADC Plus Bispecific Yields Double PFS of Chemotherapy at 2 Years in R/R LBCL, With Lowest CRS Rate Seen

Prolonged follow-up showed superior PFS with mosun-pola versus R-GemOx in the overall SUNMO population (HR, 0.41) alongside ...
The American Journal of Managed Care

Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV

Implementation barriers remain largely programmatic, requiring integrated HIV testing, adherence support, STI services, and ...
The American Journal of Managed Care

Walcker Named President of Cardinal’s The Specialty Alliance, With Strengths in GI, Urology

Walcker will oversee enterprise strategy, operations, and growth at The Specialty Alliance, while James Weber, MD, focuses on ...